The Carvedilol Hibernation Reversible Ischaemia Trial, Marker of Success (CHRISTMAS) study: Methodology of a randomised, placebo controlled, multicentre study of carvedilol in hibernation and heart failure

International Journal of Cardiology

Volumn 72, Issue 3, 2000, Pages 265-274

  Pennell, Dudley J ^a   Ray, Simon G ^b   Davies, Glyn ^a   Burgess, Malcolm ^b   Webster, Jane ^a   Slomka, Piotr ^c   Atkinson, Paul ^b   Cleland, John G F ^d  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Carvedilol; Heart failure; Hibernation; Myocardial perfusion imaging and viability

Indexed keywords

CARVEDILOL; GLYCERYL TRINITRATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; MYOCARDIAL HIBERNATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADRENERGIC BETA-ANTAGONISTS; CARBAZOLES; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL STUNNING; PROPANOLAMINES; RADIOPHARMACEUTICALS; STROKE VOLUME; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033953561     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(99)00198-9     Document Type: Article

References (55)

1. Langenburg S.E., Buchanan S.A., Blackbourne L.H., Scheri R.P., Sinclair K.N., Martinez J., Spotnitz W.D., Tribble C.G., Kron I.L. Predicting survival after coronary revascularisation for ischemic cardiomyopathy. Ann Thorac Surg. 60:1995;1193-1197.
2. Milano C.A., White W.D., Smith L.R., Jones R.H., Lowe J.E., Smith P.K., Trigt P.V. Coronary artery bypass in patients with severely depressed ventricular function. Ann Thorac Surg. 56:1993;487-493.
3. Mickleborough L.L., Maruyama H., Takagi Y., Mohamed S., Sun Z., Ebisuzaki L. Results of revascularisation in patients with severe left ventricular dysfunction. Circulation. 92:(Suppl II):1995;73-79.
4. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. New Engl J Med. 334:1996;1349-1355.
5. Packer M., Colucci W.S., Sackner-Bernstein J.D., et al. Double-blind, placebo controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Circulation. 94:1996;2793-2799.
6. Colucci W.S., Packer M., Bristow M.R., et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation. 94:1996;2800-2806.
7. Waagstein F., Hjalmarson A., Varnauskas E., Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 37:1995;1022-1036.
8. Di Lenarda A., Gilbert E.M., Olsen S.L., Mealy P.C., Bristow M.R. Acute hemodynamic effects of carvedilol versus metoprolol in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 17:1991;142A.
9. Effects of carvedilol, a vasodilator-beta-blocker, in patients with heart failure or ischemic heart disease. Circulation. 92:1995;212-218.
10. Bristow M.R., Gilbert E.M., Abraham W.T., et al. Carvedilol produces dose related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation. 94:1996;2807-2816.
11. Woodley S.L., Gilbert E.M., Anderson J.L., et al. Beta-blockade with Bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation. 84:1991;2426-2441.
12. Cleland J.G.F., Bristow M.R., Erdmann E., Remmes W.J., Swedberg K., Waagstein F. Beta-blocking agents in heart failure. Should they be used and how? Eur Heart J. 17:1996;1629-1639.
13. Olsen S.L., Gilbert E.M., Renhend D.G., Bristow M.R. Carvedilol improves left ventricular function and symptoms in chronic heart failure, a double blind randomised study. J Am Coll Cardiol. 25:1995;1225-1231.
14. Elsasser A., Schlepper M., Klovekorn W.P., et al. Hibernating myocardium. An incomplete adaptation to ischaemia. Circulation. 96:1997;2920-2931.
15. Schwartz E.R., Schpaer J., vom Dahl J., et al. Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol. 27:1996;1577-1585.
16. Cigarroa C.G., de Filippi C.R., Brickner M.E., Alvarez L.G., Wait M.A., Grayburn P.A. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularisation. Circulation. 88:1993;430-436.
17. Zimmerman R., Mall G., Rauch B., et al. Residual Tl-201 activity in irreversible defects as a marker of myocardial viability. Clinicopathological study. Circulation. 91:1995;1016-1021.
18. Maes A.F., Borgers M., Flameng W., et al. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow up. J Am Coll Cardiol. 29:1997;62-68.
19. Pennell D.J., Underwood S.R., Swanton R.H., Walker J.M., Ell P.J. Dobutamine thallium myocardial perfusion tomography. J Am Coll Cardiol. 18:1991;1471-1479.
20. Pennell D.J., Mavrogeni S., Forbat S.M., Karwatowski S.P., Underwood S.R. Adenosine combined with dynamic exercise for myocardial perfusion imaging. J Am Coll Cardiol. 25:1995;1300-1309.
21. Cuocolo A., Maurea S., Pace L., et al. Resting technetium-99m methoxyisobutylisonitrile cardiac imaging in chronic coronary artery disease: comparison with rest-redistribution thallium-201 scintigraphy. Eur J Nucl Med. 20:1993;1186-1192.
22. Cuocolo A., Pace L., Ricciardelli B., Chiariello M., Trimarco B., Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutylisonitrile. J Nucl Med. 33:1992;505-511.
23. 99mTc-sestamibi. Circulation. 89:1994;2552-2561.
24. Kauffman G.J., Boyne T.S., Watson D.D. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol. 27:1996;1592-1597.
25. Marinho N.V.S., Keogh B.E., Costa D.C., Lammerstma A.A., Ell P.J., Camici P.G. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilisation. Circulation. 93:1996;737-744.
26. Vanoverschelde J.J., Wijns W., Depre C., et al. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of non-infarcted collateral dependent myocardium. Circulation. 87:1993;1513-1523.
27. Fallen E.L., Nahmias C., Scheffel A., et al. Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease. Circulation. 91:1995;1381-1388.
28. Bisi G., Podio V., Sciagra R. Detection of myocardial viability with Tc-99m-labeled myocardial perfusion agents. Q J Nucl Med. 40:1996;68-75.
29. Goldstein R.E., Stinson E.B., Scherer J.L., Seningen R.P., Grehl T.M., Epstein S.E. Intraoperative coronary collateral function in patients with coronary occlusive disease: nitroglycerin responsiveness and angiographic correlations. Circulation. 49:1974;298-308.
30. Bisi G., Sciagra R., Santoro G.M., et al. Sublingual isosorbide dinitrate to improve technetium-99m-teboroxime perfusion defect reversibility. J Nucl Med. 35:1994;1274-1278.
31. Bisi G., Sciagra R., Santoro G.M., Fazzini P.F. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of post-revascularisation outcome of asynergic territories. J Am Coll Cardiol. 24:1994;1282-1289.
32. Maurea S., Cuocolo A., Soricelli A., et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med. 36:1995;1945-1952.
33. Bisi G., Sciagra R., Santoro G.M., et al. Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict post-revascularisation recovery. J Nucl Med. 36:1995;1994-2000.
34. Sciagra R., Bisi G., Santoro G.M., et al. Influence of the assessment of defect severity intravenous nitrate administration during tracer injection on the detection of viable hibernating myocardium with data-based quantitative technetium 99m-labeled sestamibi single-photon emission computed tomography. J Nucl Cardiol. 3:1996;221-230.
35. Sciagra R., Bisi G., Santoro G.M., et al. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting post-revascularisation recovery. J Am Coll Cardiol. 30:1997;384-391.
36. de May C., Erb K., Zimmermann T., et al. Clinical pharmacological equivalence of a novel FCH-free GTN spray with low ethanol content vs. a FCH-containing GTN spray. Eur J Clin Pharmacol. 47:1995;437-443.
37. Dewland P.M., Tanner T., Woodward A.J. Study of bioavailabilities of glyceryl trinitrate spray formulations as a basis for equivalent dosaging in cardiac emergency. Herz und Gefasse. 10:1987;3-7.
38. Dakik H.A., Howell J.F., Lawrie G.M., et al. Assessment of myocardial viability with Tc-99m-sestamibi tomography before coronary bypass graft surgery. Correlation with histopathology and postoperative improvement in cardiac function. Circulation. 96:1997;2892-2898.
39. Medrano R., Lowry R.W., Young J.B., et al. Assessment of myocardial viability with Tc-99m-sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathologic study. Circulation. 94:1996;1010-1017.
40. Bodenheimer M.M., Banka V.S., Hermann G.A., Trout R.G., Pasdar H., Helfant R.H. Reversible asynergy. Histopathologic and electrographic correlations in patients with coronary artery disease. Circulation. 53:1976;792-796.
41. Dubnow M.H., Burchell H.B., Titus J.L. Postinfarction ventricular aneurysm. A clinicomorphologic and electrocardiographic study of 80 cases. Am Heart J. 70:1965;753-760.
42. Heger J.J., Weyman A.E., Wann L.S., Dillon J.C., Feigenbaum H. Cross sectional echocardiography in acute myocardial infarction: detection and localisation of regional left ventricular asynergy. Circulation. 60:1979;531-538.
43. The TRAndolapril Cardiac Evaluation (TRACE) study: rationale, design, and baseline characteristics of the screened population. Am J Cardiol. 73:1994;44C-50C.
44. Kober L., Torp-Pedersen C., Carlsen J.E., et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. New Engl J Med. 333:1995;1670-1676.
45. Forrester A.L., Fetterman R., Zaret B.L., Wackers F.J.Th. Rapid radionuclide-derived systolic and diastolic cardiac function using cycle-dependent background correction and Fourier analysis. Proceedings on Computers in Cardiology, Linkoping, Sweden :1985.
46. Nelson A.D., Muswick G.J., Muzie R.F., Descamps X. A robust edge detection method for gated radionuclide ventriculograms. J Nucl Med. 37:1996;685-689.
47. Slomka P.J., Hurwitz G., Stephenson J.A., Cradduck T.D. Automated alignment and sizing of myocardial stress and rest scans to three-dimensional normal templates using an image registration algorithm. J Nucl Med. 36:1995;1115-1122.
48. Slomka P.J., Hurwitz G., St. Clement G., Stephenson J.A. Three-dimensional demarcation of perfusion zones corresponding to specific coronary arteries: application for automated interpretation of myocardial SPECT. J Nucl Med. 36:1995;2120-2126.
49. Ragosta M., Beller G.A., Watson D.D., Kaul S., Gimple L.W. Quantitative planar rest-redistribution Tl-201 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 5:1993;1630-1641.
50. Di Carli M.F., Asgarzadie F., Schelbert H.R., et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularisation in patients with ischemic cardiomyopathy. Circulation. 92:1995;3436-3444.
51. Germano G., Kiat H., Kavanagh P.B., et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 36:1995;2138-2147.
52. Germano G., Kavanagh P.B., Chen J., et al. Operator-less processing of myocardial perfusion SPECT studies. J Nucl Med. 36:1995;2127-2132.
53. Germano G., Erel J., Lewin H., Kavanagh P.B., Berman D.S. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single photon emission computed tomography. J Am Coll Cardiol. 30:1997;1360-1367.
54. DePuey E.G., Nichols K., Dobrinsky C. Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT. J Nucl Med. 34:1993;1871-1876.
55. Chua T., Kiat H., Germano G., et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thalliu-201 scintigraphy. J Am Coll Cardiol. 23:1994;1107-1114.